Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
32.99
+1.00 (3.13%)
Nov 21, 2025, 4:00 PM EST - Market closed
Smith & Nephew Revenue
Smith & Nephew had revenue of $2.96B in the half year ending June 28, 2025, with 8.30% growth. This brings the company's revenue in the last twelve months to $5.94B, up 5.35% year-over-year. In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth.
Revenue (ttm)
$5.94B
Revenue Growth
+5.35%
P/S Ratio
2.34
Revenue / Employee
$329,125
Employees
18,060
Market Cap
13.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SNN News
- 16 days ago - Smith & Nephew plc (SNN) Q3 2025 Sales Call Transcript - Seeking Alpha
- 17 days ago - Smith & Nephew: Expensive Valuations And Muted Growth May Dampen Upcoming Q3 Earnings Release - Seeking Alpha
- 26 days ago - Smith+Nephew comparative study1 shows PICO◊ sNPWT (-80 mmHg) delivers superior performance in relation to wound dehiscence and reduces healthcare costs across cardiovascular and orthopedic surgery versus PrevenaTM -125 mmHg sNPWT - GlobeNewsWire
- 4 weeks ago - UFC® and Smith+Nephew announce multi-year extension of partnership - GlobeNewsWire
- 7 weeks ago - Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention - GlobeNewsWire
- 7 weeks ago - Smith+Nephew launches CORIOGRAPH™ Pre-Op Planning and Modeling Services for total shoulder arthroplasty - GlobeNewsWire
- 2 months ago - Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant - GlobeNewsWire
- 2 months ago - Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System - GlobeNewsWire